MX2009005446A - Sistema de suministro vaginal para mirtazapina. - Google Patents

Sistema de suministro vaginal para mirtazapina.

Info

Publication number
MX2009005446A
MX2009005446A MX2009005446A MX2009005446A MX2009005446A MX 2009005446 A MX2009005446 A MX 2009005446A MX 2009005446 A MX2009005446 A MX 2009005446A MX 2009005446 A MX2009005446 A MX 2009005446A MX 2009005446 A MX2009005446 A MX 2009005446A
Authority
MX
Mexico
Prior art keywords
mirtazapine
delivery system
vaginal delivery
polymer
formulation
Prior art date
Application number
MX2009005446A
Other languages
English (en)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005446A publication Critical patent/MX2009005446A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a una formulación de liberación prolongada que contiene mirtazapina sólida, cuya formulación en un dispositivo vaginal que tiene una piel y cuyo dispositivo comprende un compartimiento interior elaborado de un polímero termoplástico, cuyo polímero contiene mirtazapina. El polímero preferiblemente está elaborado de copolímero de etileno y acetato de vinilo.
MX2009005446A 2006-11-22 2007-11-21 Sistema de suministro vaginal para mirtazapina. MX2009005446A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86075306P 2006-11-22 2006-11-22
EP06124593 2006-11-22
PCT/EP2007/062654 WO2008062021A1 (en) 2006-11-22 2007-11-21 Vaginal delivery system for mirtazapine

Publications (1)

Publication Number Publication Date
MX2009005446A true MX2009005446A (es) 2009-06-02

Family

ID=38974691

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005446A MX2009005446A (es) 2006-11-22 2007-11-21 Sistema de suministro vaginal para mirtazapina.

Country Status (7)

Country Link
US (1) US20100129425A1 (es)
EP (1) EP2091541A1 (es)
JP (1) JP2010510290A (es)
AU (1) AU2007324467A1 (es)
CA (1) CA2669833A1 (es)
MX (1) MX2009005446A (es)
WO (1) WO2008062021A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062008A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for a non-steroidal non-ionized hydrophilic drug
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2734262B1 (en) * 2011-07-20 2018-02-28 Patrick F. Kiser Intravaginal rings for drug delivery
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
WO2005004837A1 (en) * 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
TW200631584A (en) * 2004-11-15 2006-09-16 Akzo Nobel Nv A medicament related to mirtazapine for the treatment of hot flush

Also Published As

Publication number Publication date
JP2010510290A (ja) 2010-04-02
EP2091541A1 (en) 2009-08-26
CA2669833A1 (en) 2008-05-29
US20100129425A1 (en) 2010-05-27
WO2008062021A1 (en) 2008-05-29
AU2007324467A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
MX2009005445A (es) Sistema de suministro para risperidona.
MX2009005446A (es) Sistema de suministro vaginal para mirtazapina.
WO2008057867A3 (en) Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
WO2010088697A3 (en) Antimicrobial accessory for an implantable medical device
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
WO2010019597A3 (en) Cyclo olefin polymer and copolymer medical devices
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
WO2011028846A3 (en) Cannula insertion device systems and methods
WO2011143500A3 (en) Self contained illuminated infusion cannula systems and devices
MX2007003729A (es) Dispositivo medico y sistema de colocacion de pelicula delgada.
HK1200747A1 (en) Integrated intra-dermal delivery, diagnostic and communication system
WO2008002434A3 (en) Medical devices for release of low solubility therapeutic agents
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
WO2008063341A3 (en) Dual action, inhaled formulations providing both an immediate and sustained release profile
WO2012017063A3 (en) Method and system for retaining a cartridge in a holder
MX2008014794A (es) Liberacion controlada de opioides fenolicos.
WO2008078318A3 (en) Systems and devices for sustained delivery of therapeutic fluid
WO2008148478A3 (de) Gastroretentives system mit alginat-körper
CR11493A (es) Sistema de administracion vaginal
WO2012091748A3 (en) Therapeutic agent reservoir delivery system
WO2008093851A1 (ja) 体腔用医療機器及びその製造方法
MY161465A (en) Seed treatment formulations and methods of use
WO2013009998A3 (en) Device for delivery of antimicrobial agent into trans-dermal catheter
WO2009105432A3 (en) Devices and methods for delivery of a therapeutic agent through a pneumostoma
WO2010096733A3 (en) Luminescent porous silicon nanoparticles, methods of making and using same

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal